<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396719</url>
  </required_header>
  <id_info>
    <org_study_id>CTO130-P001</org_study_id>
    <nct_id>NCT02396719</nct_id>
  </id_info>
  <brief_title>A Real-World Registry to Investigate the Performance of LenSx® Laser in Chinese Patients</brief_title>
  <official_title>A Prospective, Single-Arm, Multicenter, Registry Study to Investigate the Performance of Femtosecond Laser-Assisted Cataract Surgery in Chinese Cataract Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the performance of LenSx® Laser in femtosecond
      laser-assisted cataract surgery (FLACS) in real-world medical practice in Chinese patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will undergo FLACS using the LenSx® Laser system. The recommended postoperative
      visits will follow the current standard of care in China.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Completion rate of a round anterior capsulotomy</measure>
    <time_frame>Surgery (Day 0)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Completion rate of lens fragmentation without additional segmentation after LenSx Laser procedure</measure>
    <time_frame>Surgery (Day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completion rate of intraocular lens (IOL) implantation</measure>
    <time_frame>Surgery (Day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completion rate of corneal incisions</measure>
    <time_frame>Surgery (Day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best-corrected distance visual acuity (BCDVA)</measure>
    <time_frame>Up to Day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with BCDVA of 20/20, 20/25, 20/40 or better at each visit</measure>
    <time_frame>Up to Day 30</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1541</enrollment>
  <condition>Cataracts</condition>
  <arm_group>
    <arm_group_label>LenSx</arm_group_label>
    <description>Phacoemulsification cataract surgery in at least 1 eye using LenSx® Laser technology</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LenSx® Laser</intervention_name>
    <description>Used for cornea incision, capsulotomy and lens fragmentation during cataract surgery</description>
    <arm_group_label>LenSx</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese patients who undergo cataract surgery using LenSx® Laser and phacoemulsification in
        at least one eye will be eligible to participate.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chinese;

          -  Will undergo LenSx® Laser-assisted cataract surgery and phacoemulsification in at
             least one eye;

          -  Must sign written informed consent;

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Contraindications listed in LenSx® Laser System Operator's Manual;

          -  Pregnant, nursing, or planning a pregnancy;

          -  Concurrent enrollment in another investigational drug and/or device study or
             participation in such a study within 30 days prior to surgery day;

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zuojun Gao, Medical Affairs Director</last_name>
    <role>Study Director</role>
    <affiliation>Alcon China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alcon China Ophthalmic Product Co., Ltd.</name>
      <address>
        <city>Beijing</city>
        <zip>100016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2015</study_first_submitted>
  <study_first_submitted_qc>March 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>June 3, 2016</last_update_submitted>
  <last_update_submitted_qc>June 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

